Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Effects of Analgecine on Oxaliplatin-Induced Neurotoxicity in Patients with Gastrointestinal Cancer

  • Liu, Meng-Yan (Department of Chemotherapy, the Affiliated Jiangsu Cancer Hospital of Nanjing Medical University & Jiangsu Institute of Cancer Research) ;
  • Huang, Xin-En (Department of Chemotherapy, the Affiliated Jiangsu Cancer Hospital of Nanjing Medical University & Jiangsu Institute of Cancer Research)
  • Published : 2015.06.03
Download PDF
⟨ Previous Next ⟩

Abstract

Background: As the third generation of platinum-based antineoplastic agent aginst gastrointestinal cancer, oxaliplatin is considered to be associated with severe sensory neurotoxicity. Acorrding to previous studies, vitaminE, intravenous Ca/Mg and glutamine may partly reduce the incidence and severity of oxaliplatin-induced neurotoxicity. The aim of this study was to investigate the safety and efficacy of analgecine for preventing oxaliplatin-induced neurotoxicity in the patients with gastrointestinal tumors. Method: In this study, patients undergoing oxaliplatin-based chemotherapy were assigned to analgecine (experimental) group or control group. Analgecine 6ml was administered once a day for seven days from the day of oxaliplatin treatment. The National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE; version 3) was used to evaluate oxaliplatin-induced neurotoxicity. The incidence rates and grade of neurotoxicity of patients were assessed before and during (after four and eight cycles) treatment. Results: Totally, 82 patients were enrolled in this study, 42 in experimental group and 40 in control group. The occurrence of each grade neurotoxicity in the experimental group was significantly lower than that in control group. The overall occurrence rate was 31% vs 55% (P=0.043) after 4 cycles and 52% vs 75% (P=0.050) after 8 cycles. Conclusion: Analgecine appears could be effective in reducing oxaliplatin-induced neurotoxicity and be applicated for patients with gastrointestinal tumors who would be treated with oxaliplatin-based chemotherapy.

Keywords

References

  1. Durand JP, Deplanque G, Montheil V, et al (2012). Effiacy of venlafaxine for the prevention and relief of oxaliplatininduced acute neurotoxicity: resultsof eFFOX, a randomized, double-blind, placebo-controlled phaseIII trial. Ann Oncol, 23, 200-5. https://doi.org/10.1093/annonc/mdr045
  2. Fu XR, Dong XH, Sun ZC, et al (2010). Clinical Observation to Combination Treatment of Lipoic Acid and Analgecine for Chemotherapy- induced Peripheral Neuropathy. Chin General Pract, 1007-9572.
  3. Gamelin L, Boisdron-Celle M, Morel A, et al (2005). Oxaliplatinrelated neurotoxicity: Interest of calciummagnesium infusion and no impact on its efficacy. J Clin Oncol, 26, 1188-9.
  4. Grothey A, Nikcevich DA, Sloan JA, et al (2010). Intravenous calcium and magnesium for oxaliplatin-induced sensory neurotoxicity in adjuvant colon cancer: NCCTG N04C7. J Clin Oncol, 29, 421-7.
  5. Han CH, Khwaounjoo P, Kilfoyle DH, Hill A, McKeage MJ (2013). Phase I drug-interaction study of effects of calcium and magnesium infusions on oxaliplatin pharmacokinetics and acute neurotoxicity in colorectal cancer patients. BMC Cancer, 13, 495 https://doi.org/10.1186/1471-2407-13-495
  6. Kono T, Hata T, Morita S, et al (2013). Goshajinkigan oxaliplatin neurotoxicity evaluation (GONE): a phase 2, multicenter, randomized, double blind, placebo controlled trial of goshajinkigan to prevent oxaliplatin induced neuropathy. Cancer Chemo Pharmacol, 72, 1283-90. https://doi.org/10.1007/s00280-013-2306-7
  7. Li YH, Chen J, Xu X, et al (2009). Clinical observation of treatment diabetic peripheral neuropathy with analgecine. Guide China Med, 1671-8194, 2009, 13-0035-03.
  8. Lisa A. Kottschade, Jeff A. Sloan, Miroslaw A. Mazurczak, et al (2011). The use of vitamin E for the prevention of chemotherapyinduced peripheral neuropathy: results of a randomized phase III clinical trial. Support Care Cancer. 2011 November, 19, 1769-77.
  9. Liu J, Huang XE, Feng JF, et al (2014). Further Study on Pemetrexed based chemotherapy in Treating Patients with Advanced Gastric Cancer (AGC). Asian Pac J Cancer Prev, 15, 6587-90. https://doi.org/10.7314/APJCP.2014.15.16.6587
  10. Liu ZB, et al (2005). Extract from Rabbit Skin Inflamed by Vaccinia Virus for Injection- Analgecine. Qilu Pharmacol Affairs, 1672-7738 (2005) 08- 0509- 02.
  11. Wang WS, Lin JK, Chen PM , et al (2007). Oral Glutamine Is Effective for Preventing Oxaliplatin-Induced Neuropathy in Colorectal Cancer Patients. The Oncologist, 12, 312-9. https://doi.org/10.1634/theoncologist.12-3-312
  12. Wu XY, Huang XE, et al (2014). A Predictive Model for Evaluating Responsiveness to Pemetrexed Treatment in Patients with Advanced Colorectal Cancer. Asian Pac J Cancer Prev, 15, 5941-4. https://doi.org/10.7314/APJCP.2014.15.14.5941
  13. Wu XY, Huang XE, You SX, et al (2013). Phase II study of pemetrexed as second or third line combined chemotherapy in patients with colorectal cancer. Asian Pac J Cancer Prev, 14, 2019-22. https://doi.org/10.7314/APJCP.2013.14.3.2019
  14. Xiao Y, Liu J, Liu YC, Huang XE, et al (2014). Phase II Study on EANI Combined with Hydrochloride Palonosetron for Prevention of Chemotherapy-induced Nausea and Vomiting Following Highly Emetogenic Chemotherapy. Asian Pac J Cancer Prev, 15, 3951-4. https://doi.org/10.7314/APJCP.2014.15.9.3951
  15. Yu H, Ji J, Ma CH, et al (2013). Efficacy of glutathione in prevention of neurotxicity induced by oxaliplatin. Modern Oncology, 21, 1342-3.
  16. Zhu YY, Yang JL, Jiao SC, et al (2007). Ganglioside-monosialic acid (GM1) prevents oxaliplatin-induced peripheral neurotoxicity in patients with gastrointestinal tumors. World J Surg Oncol, 2013, 11-9.

Cited by

  1. Safety and Efficacy of a Mouth-Rinse with Granulocyte Colony Stimulating Factor in Patients with Chemotherapy-Induced Oral Mucositis vol.17, pp.1, 2016, https://doi.org/10.7314/APJCP.2016.17.1.413
  2. A Clinical Study on Juheli (Recombinant Human Interleukin - 11) in the Second Prevention of Chemotherapy Induced Thrombocytopenia vol.17, pp.2, 2016, https://doi.org/10.7314/APJCP.2016.17.2.485
  3. Effect of Peripheral Blood CD4 + CD25 + Regulatory T Cell on Postoperative Immunotherapy for Patients with Renal Carcinoma vol.17, pp.4, 2016, https://doi.org/10.7314/APJCP.2016.17.4.2027
  4. Herbal Medicine AC591 Prevents Oxaliplatin-Induced Peripheral Neuropathy in Animal Model and Cancer Patients vol.8, pp.1663-9812, 2017, https://doi.org/10.3389/fphar.2017.00344